F
$ Value
$8K
Shares
4,966
Price
$2
Filed
Mar 5
Insider
Name
Albert Benjamin
Title
CEO
CIK
0002086403
Roles
Director
Officer
Transaction Details
Transaction Date
2026-03-02
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,528,433
Footnotes
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Filing Info
Albert Benjamin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-10 | HCAT | F | $130K |
| 2026-03-02 | HCAT | F | $8K |
| 2026-02-26 | HCAT | F | $23K |
| 2026-02-25 | HCAT | A | $0 |
| 2026-02-25 | HCAT | A | $0 |
| 2025-09-24 | HCAT | A | $0 |
Other Insiders at HCAT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Llewelyn Linda
Chief People Officer
|
— | — | 2026-03-02 |
| Gallagher Duncan | — | — | 2026-02-17 |
| Larson-Green Julie | — | — | 2026-03-01 |
|
Alger Jason
Chief Financial Officer
|
— | — | 2026-03-02 |
|
Landry Benjamin
General Counsel
|
— | — | 2026-03-02 |
|
Albert Benjamin
CEO
|
— | — | 2026-03-10 |